ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,215,087, issued on Feb. 4, was assigned to BioAge Labs Inc. (Richmond, Calif.).
"Inhibitors of NLRP3 inflammasome" was invented by George Hartman (Lansdale, Pa.), Paul Humphries (Menlo Park, Calif.) and Kevin Edward Leif Wilhelmsen (Albany, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compounds that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with inflammation and inflammaging, including hearing loss and other diseases associated with aging."
The patent was filed on July 17, 2023, under Application No. 18/353,422.
...